Nu Skin(US:NUS)2025-11-06 22:00Q3 2025 Performance - Q3 2025 revenue was $364.2 million, a decrease of 15.3% year-over-year, or 11.5% excluding Rhyz's Mavely, with a foreign exchange impact of -0.4% or -$1.7 million[6] - Q3 2025 EPS was $0.34, compared to $0.17 in the prior year[6] - Customer count decreased by 10%, Paid Affiliates by 13%, and Sales Leaders by 19% year-over-year[6] - Revenue distribution shows Mainland China accounting for 12%, Americas 9%, South Korea 10%, Southeast Asia/Pacific 15%, Japan 12%, Europe & Africa 14%, and Hong Kong/Taiwan 18% of the total[6] Regional Performance (Revenue) - Mainland China's revenue decreased by 20% to $42.5 million[10] - Americas revenue decreased by 17% to $64.0 million[10] - South Korea's revenue decreased by 22% to $35.2 million[10] - Europe & Africa revenue decreased by 1% to $38.0 million[10] Q4 2025 Outlook - The company projects Q4 2025 revenue to be between $365 million and $400 million, representing a decrease of 18% to 10%, or 12% to 3% excluding Mavely 2024 revenue, with an approximate 1% negative foreign exchange impact[24] - Q4 2025 EPS is projected to be between $0.25 and $0.35[24] Full Year 2025 Outlook - The company anticipates full-year 2025 revenue to be between $1.48 billion and $1.51 billion, a decrease of 15% to 13%, or 11% to 9% excluding Mavely 2024 revenue, with an approximate 1% negative foreign exchange impact[24] - Full-year 2025 EPS is projected to be between $3.15 and $3.25, or $1.25 to $1.35 excluding the Mavely gain and other charges[24]